Tag: data
NTT DATA Business Solutions receives SAP S/4HANA® Cloud Partner of the...
In the Diamond Initiative, NTT DATA Business Solutions AG has received an award for "SAP S/4HANA® Cloud Partner of the Year 2023" from...
According to Wingie’s Data, 75% of Travelers were Solo in the...
DUBAI, UAE and BERLIN, March 21, 2023 /PRNewswire/ -- Travel trends shift each year according to consumer behavior and solo travel is rising in...
EISAI PUBLISHES SOCIETAL VALUE OF LECANEMAB USING PHASE 3 CLARITY AD...
TOKYO, March 19, 2023 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") today announced the publication of updated results from...
Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful,… –...
Patients treated with investigational bimekizumab, an IL-17A and IL-17F inhibitor, achieved statistically significant and clinically meaningful improvements over placebo in signs and symptoms...
Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the...
ZUG, Switzerland, March 18, 2023 (GLOBE NEWSWIRE) -- Pharvaris PHVS, a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and...
Bone & Joint Clinic, S.C. – Notice of Data Security Incident...
WAUSAU, Wis., March 10, 2023 /PRNewswire/ -- Bone & Joint Clinic, S.C. ("Bone & Joint"), an orthopedic and pain management clinical practice located...
Ocean Biomedical (NASDAQ: OCEA) Shares Detailed Research Data on Anti-Tumor Path…...
Providence, RI, March 09, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. OCEA. Ocean Biomedical's Scientific Co-founder, Dr. Jack A. Elias, MD,...
Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Uni… –...
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS mutationPhase 1/2a clinical trial with IMM-1-104 underway in patients...
Additional Data on Lumos OraGrowtH Trials Presented at International Meeting of...
Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data AnalysisBaseline Characteristics of OraGrowtH210 Trial Subjects Highlighted...
Late-Breaking Data from Landmark COAPT Trial Show Long-Term Benefits of Abbott’…...
New five-year data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine reinforce...